What the papers say – weekly digest (05/04/24)
Your weekly digest of the top healthcare stories, covering news published from 01/04/2024 – 05/04/2024. The Guardian Patients are dying needlessly every year due to vulnerable Britons with… read more.
Your weekly digest of the top healthcare stories, covering news published from 01/04/2024 – 05/04/2024. The Guardian Patients are dying needlessly every year due to vulnerable Britons with… read more.
Short-term very low calorie diets are safe for teenagers living with moderate to severe obesity when closely monitored by an experienced dietitian, new research to be presented at… read more.
A collaborative study between a bariatric and transplant surgery team has introduced new hope for patients suffering from end-stage renal disease (ESRD) who are also struggling with obesity…. read more.
Novo Nordisk announced that the FDA has approved a label expansion for Wegovy based on a supplemental New Drug Application (sNDA) for the indication of reducing risks of… read more.
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) drug use appears to be associated with increased residual gastric content (RGC) detected by gastric ultrasonography, a major risk factor for aspiration… read more.
Ben-Gurion University of the Negev and Soroka University Medical Center researchers have found that tonsillectomy in children with obstructive sleep apnea does not increase the risk of obesity… read more.
People with type 2 diabetes who underwent bariatric surgery achieved better long-term blood glucose control compared to people who received medical management plus lifestyle interventions, according to a… read more.
Clocking up high weekly levels of moderate to vigorous intensity physical activity is linked to a lower risk of developing chronic kidney disease in overweight/obese people with type… read more.
The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took… read more.
Science has named the development of glucagon like peptide-1 (GLP-1) agonists and this year’s discovery that these drugs can blunt obesity-associated health problems as its 2023 Breakthrough of The… read more.
UK organisations responsible for protecting the public from prescription-only drug adverts are putting patients at risk from the harms of weight loss drugs by not enforcing the law,… read more.
The vast majority of older adults – 83% — think health insurers should cover medications that can help people with obesity manage their weight, a new poll of people… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.